Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TumorSight Viz

K-Number: K231130 · 2023-12-26

ApplicantSimBioSys, Inc.
Decision Date2023-12-26
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

TumorSight Viz is a medical device manufactured by SimBioSys, Inc.. It received FDA 510(k) clearance on 2023-12-26 under approval number K231130. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TumorSight Viz?

TumorSight Viz is a medical device that received FDA 510(k) clearance on 2023-12-26. It is manufactured by SimBioSys, Inc.. The 510(k) number is K231130.

When was TumorSight Viz approved by the FDA?

TumorSight Viz received FDA 510(k) clearance on 2023-12-26, under approval number K231130.

What company makes TumorSight Viz?

TumorSight Viz is manufactured by SimBioSys, Inc..

What is the FDA product code for TumorSight Viz?

The FDA product code for TumorSight Viz is QIH.

Other Devices by SimBioSys, Inc.

K243189TumorSight Viz K251766TumorSight Viz

Related Devices (Code: QIH)

K191647QLAB Advanced Quantification SoftwarePhilips Health Care K191171EchoGo CoreUltromics, Ltd. K201195syngo.via MI Workflows, syngo MBFSiemens Medical Solutions USA, Inc. K202013WRDensity by Whiterabbit.aiWhiterabbit.Ai, Inc. K202546LVivo SeamlessDia Imaging Analysis, Ltd. K193283AI-Rad Companion Prostate MRSiemens Medical Solutions USA, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑